Human Factor Validation of Pediatric Mobility Device

NCT ID: NCT03714256

Last Updated: 2021-01-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-21

Study Completion Date

2018-11-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to validate the user interface of a pediatric power mobility device by establishing that the product is safe and effective use for the intended users.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to validate the user interface of a pediatric power mobility device by establishing that the product is safe and effective use for the intended users. The human factors validation study will be conducted in children with mobility impairments as categorised by Hays (1987) in the age range of 6 months to 36 months under realistic use conditions.The study is an open label, un-blinded, non-randomized study which consists of one visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disability Physical

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children 6-17 months

Device, patient mobility, powered:

Usability of the pediatric mobility device by both parent/guardian and occupational/physiological therapist, performed according to instructions for use at a one time occasion.

Group Type EXPERIMENTAL

Device, patient mobility, powered

Intervention Type DEVICE

Pediatric mobility device

Children 18 - 36 months

Device, patient mobility, powered:

Usability of the pediatric mobility device by both parent/guardian and occupational/physiological therapist, performed according to instructions for use at a one time occasion.

Group Type EXPERIMENTAL

Device, patient mobility, powered

Intervention Type DEVICE

Pediatric mobility device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Device, patient mobility, powered

Pediatric mobility device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Primary users:

* Informed consent signed by parents or guardian
* Aged 6-36 months
* Unable to mobilize independently for exploratory play and peer interaction, as categorized by Hays (1987)
* Adequate trunk and head control to remain upright in the device, including regain head control
* Adequate hand/ arm (distal) control to reach for objects in front of them

Secondary users:

* Signed informed consent
* Physiotherapist/Occupational Therapist or parent/guardian of the child included in the test

Exclusion Criteria

* Primary users:

* Weight \>16 kg/35 Ibs
* Length \>100 cm/39 In
* Children that lack head control in such a severe manner that they cannot regain control if it is lost
* Children who do not show awareness of or respond to toys, objects, sounds and/or people in their environment
* Any other reason, if in the opinion of the investigator, the individual user is not appropriate, or suitable for participation in the test.

Secondary users:

* Hearing/vision loss or limited cognitive skills impacting the ability to take instructions and perform the tasks of the test
* Ability to understand oral and written English as product labelling will in this Human Factor validation test only be available in English
* Any other reason, if in the opinion of the investigator, the individual user is not appropriate, or suitable for participation in the test
Minimum Eligible Age

6 Months

Maximum Eligible Age

36 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Permobil, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karin Leire

Role: STUDY_DIRECTOR

Permobil Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cincinnati Childrens Hospital Medical Center

Cincinnati, Ohio, United States

Site Status

Oregon State University

Corvallis, Oregon, United States

Site Status

Belmont University

Nashville, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Per2018P04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

FES to Improve Crouch Gait in CP
NCT04209257 COMPLETED NA